StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie contingent Consideration Liability — Total Level 3 Fair Value ($M) ($M)

Form 10-Q / 10-K Financial Instruments & Fair Value Measurements Note

QuarterlyAnnual
Latest, Q2 2026
27,495
Period ended Jun 30, 2026
Change on a year earlier
+11.5%
24,649 in Q2 2025
History
38 quarters
Since Q4 2015
Sources
32
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedContingent Consideration Liability — Total Level 3 Fair Value ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202627,495+11.5%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 202627,039+19.0%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 202525,374+17.1%Form 10-Q (filed 2026-08-03) ↗
Q3 2025Sep 30, 202524,649+12.4%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 202524,649+16.5%Form 10-Q (filed 2026-08-03) ↗
Q1 2025Mar 31, 202522,713+12.7%Form 10-Q (filed 2026-05-08) ↗
Q4 2024Dec 31, 202421,666+8.9%Form 10-Q (filed 2026-08-03) ↗
Q3 2024Sep 30, 202421,926+17.4%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 202421,150+10.4%Form 10-Q (filed 2025-08-04) ↗
Q1 2024Mar 31, 202420,159+12.4%Form 10-Q (filed 2025-05-09) ↗
Q4 2023Dec 31, 202319,890+21.4%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 202318,674+28.3%Form 10-Q (filed 2024-11-04) ↗
Q2 2023Jun 30, 202319,151+26.2%Form 10-Q (filed 2024-08-07) ↗
Q1 2023Mar 31, 202317,931+29.8%Form 10-Q (filed 2024-05-03) ↗
Q4 2022Dec 31, 202216,384+10.1%Form 10-K (filed 2026-02-20) ↗
Q3 2022Sep 30, 202214,556-2.4%Form 10-Q (filed 2023-11-06) ↗

Breakdown

What makes up contingent consideration liability — total level 3 fair value ($m)

Cite this data

StockData. (2026). AbbVie Contingent Consideration Liability — Total Level 3 Fair Value ($M) ($M), quarterly Q4 2015–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cc_liab_tot

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.